Gene therapy using plants
Active Other Transaction Agreement Awarded Last action
- Contract number
- 140D042490002
- Awardee
-
Vecprobio Inc. UEI VES5VBS3VM25
- Awarding agency
-
Interior Business Center
Office of Policy Management and Budget, Department of the Interior
- Obligated
- $46,567,436
Award facts
- Contract value 76% obligated
-
- $46,567,436.00 Current, with exercised options
- $61,152,930.00 Potential, with all options
- Completion date 52% complete
-
- Current, with exercised options
- Potential, with all options
- Funding agency
- National Institutes of Health Department of Health and Human Services
- NAICS code
- Not on record
- PSC
- AJ11 General Science And Technology R&D Services; General Science And Technology; Basic Research
- Competition
- Competed Program Solicitation
- Pricing
- Other
- Place of performance
- San Diego, CA 92126, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $16,304,480 | |
| Other Administrative Action | $0 | |
| Original award | $30,262,956 |
About this award
The National Institutes of Health awarded an Other Transaction Agreement to Vecprobio Inc. (operating as Cirsium Biosciences) for transformative manufacturing of adeno-associated virus (AAV) and other gene therapies using plant-based production systems, with a ceiling value of $61.15 million and an award date of September 17, 2024.
The agreement supports rapid, safe, highly scalable, and cost-effective production of gene therapies in whole plants. Performance concludes by September 16, 2028. Work is performed in San Diego, California. As an Other Transaction Agreement, this effort sits outside the Federal Acquisition Regulation and leverages alternative authorities for prototype development and innovative manufacturing approaches in the gene therapy space.
Quick answers
Who was awarded contract 140D042490002?
140D042490002 was awarded to Vecprobio Inc. by Interior Business Center (Office of Policy Management and Budget) on September 17, 2024.
How much is contract 140D042490002 worth?
The government has obligated $46,567,436 on 140D042490002. Its potential value, with all options, is $61,152,930.
Which agency awarded contract 140D042490002?
Interior Business Center (Office of Policy Management and Budget) awarded 140D042490002, with funding from National Institutes of Health (Department of Health and Human Services).
Was contract 140D042490002 competed?
The extent of competition for 140D042490002 was competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award